Similarly, transcriptomic analysis (GSE89749) indicated ICC patients with high CLDN18 expression had a trend toward poorer overall survival (OS) (P=0.058; Figure 2C). Here, CLDN18 is linked to intrahepatic cholangiocarcinoma.